Seekyo therapeutics
Web17 Mar 2024 · Poitiers, France, March 17, 2024 – Seekyo, a startup company specializing in developing smart chemotherapy drugs, today announces that it has raised in excess of €650,000 ($775K) in bridge funding from its historic investors (business angel networks WeLike, BAdGE and Synergence), and from Bpifrance.This funding is in addition to the … WebSeekyo Therapeutics. 5mo. " #Bio €quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe" : Testimonial Seekyo Therapeutics has been elected to be member of the ...
Seekyo therapeutics
Did you know?
Web17 Jan 2024 · Seekyo is a biotechnology startup developing new-generation cancer treatments known as ‘smart chemotherapy’, selective to tumors, reducing adverse effects … WebSeekyo’s strategy includes a highly selective mechanism of drug release based on enzymatic activation, avoiding early or uncontrolled release responsible for the adverse … Seekyo raises €800k with leverage effect (Janv 2024) Discover. Seekyo’s cancer … The next generation of targeted therapy for solid cancer The next generation of targeted therapy for solid cancer
Web06 May 2024 Seekyo Therapeutics has patents pending for therapeutic vectors and prodrugs for treating cancers in the World Subscriber content You need to be a logged in … WebSEEKYO Therapeutics juin 2024 - aujourd’hui 3 ans 11 mois. Poitiers Membre du Conseil d'Administration Les Business Angels des Grandes Ecoles 2011 - aujourd’hui 12 ans. Paris Gérant Delaroche Consulting janv. 1999 - aujourd’hui 24 ans 4 mois. Membre des Bureaux Centraliens Supélec Entrepreneurs, CentraleSup Business-Angels ...
WebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPYWe aim at a high selectivity in the treatment … WebBioTech Pitch Session 4: Seekyo Therapeutics, Senolytic Therapeutics S.L., UVera - YouTube The last four pitches of the EIT Health Catapult 2024 Semi-Finals in the BioTech category were...
Web28 Mar 2024 · Seekyo Therapeutics our SKY platform is based on #clickchemistry . As a result, SKY01 our lead compound, a Tumor Activated Therapy targets selectively solid tumors to treat cancers including...
WebSEEKYO® is a privately-owned biotech company developing a Smart Chemotherapy, selective to tumors, safe for patients. We are designing smart drugs that selectively target … poundland sealand roadWebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: Tumor Activated Therapy. The lead compound SKY01 selectively targets the Micro-Environment... poundland selection box christmasWeb17 Mar 2024 · Seekyo is a biotechnology company developing new-generation cancer treatments known as ‘smart chemotherapy selective to tumors and safe for patients’. … poundland seed traysWebSeekyo Therapeutics' lead compound is #clickchemistry, so we are contributing to "improve the targeting of… Aimé par Fabien Petit-Cancelier. Voir le profil complet de Fabien Découvrir vos relations en commun Être mis en relation Contacter Fabien directement ... poundland seacroft leedsWebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPY We aim at a high selectivity in the treatment … poundland secret santaWebSeekyo, a Poitiers-based biotech startup developing new chemotherapies, has raised €800,000 in seed funding to validate its flagship tumor-targeting drug. The financing … tours for yellowstoneWebSeekyo is a biotechnology company developing the next generation of targeted therapy for solid cancer: TUMOR ACTIVATED THERAPY We aim at a high selectivity in the treatment for solid tumors,... poundland selly oak